Spots Global Cancer Trial Database for folfox protocol
Every month we try and update this database with for folfox protocol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin | NCT05494320 | Gastrointestina... | Folfox Protocol | 18 Years - | Ain Shams University | |
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas | NCT06346197 | Gastric Cancer MSI-H Metastatic Canc... Advanced Cancer | Balstilimab Botensilimab Folfox Protocol XELOX Nivolumab | 18 Years - | Centre Leon Berard | |
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | NCT03975049 | Rectal Cancer Chemotherapy Ef... | Chemoradiation FOLFOXIRI Proto... Folfox Protocol | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | NCT03259035 | Rectal Cancer | Folfox Protocol Capox | 18 Years - | Canadian Cancer Trials Group | |
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | NCT03812783 | Hepatocellular ... | Hepatic arteria... Folfox Protocol Sorafenib Hepatic arteria... FOLFIRINOX | 18 Years - 75 Years | Sun Yat-sen University | |
SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies | NCT05039944 | Colorectal Canc... | SI-B001 Irinotecan FOLFIRI Protoco... FOLFOX Protocol | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. | |
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | NCT04962958 | Carcinoma Carcinoma, Hepa... Liver Neoplasms Digestive Syste... Antineoplastic ... Donafenib Fluorouracil Oxaliplatin Antimetabolites | Hepatic arteria... Folfox Protocol Donafenib | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | NCT03975049 | Rectal Cancer Chemotherapy Ef... | Chemoradiation FOLFOXIRI Proto... Folfox Protocol | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | NCT02981498 | Hepatocellular ... | Hepatic arteria... Folfox Protocol | 18 Years - 75 Years | Sun Yat-sen University | |
SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies | NCT05039944 | Colorectal Canc... | SI-B001 Irinotecan FOLFIRI Protoco... FOLFOX Protocol | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. |